Cytochalasin B-induced structural changes in the anterior ocular segment of the cynomolgus monkey
- PMID: 98470
Cytochalasin B-induced structural changes in the anterior ocular segment of the cynomolgus monkey
Similar articles
-
Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey.Invest Ophthalmol Vis Sci. 1977 Jan;16(1):47-53. Invest Ophthalmol Vis Sci. 1977. PMID: 401776
-
Echothiophate-induced structural alterations in the anterior chamber angle of the cynomolgus monkey.Invest Ophthalmol Vis Sci. 1979 Sep;18(9):918-29. Invest Ophthalmol Vis Sci. 1979. PMID: 113361
-
Concentration-dependent morphologic effects of cytochalasin B in the aqueous outflow system.Invest Ophthalmol Vis Sci. 1980 Jul;19(7):835-41. Invest Ophthalmol Vis Sci. 1980. PMID: 6771222
-
The effects of ocular hypotensive doses of PGF2 alpha-isopropylester on anterior segment morphology.Prog Clin Biol Res. 1989;312:437-46. Prog Clin Biol Res. 1989. PMID: 2678149 Review.
-
Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva.Prog Clin Biol Res. 1989;312:39-52. Prog Clin Biol Res. 1989. PMID: 2508129 Review.
Cited by
-
Status of Rho kinase inhibitors in glaucoma therapeutics-an overview.Int Ophthalmol. 2022 Jan;42(1):281-294. doi: 10.1007/s10792-021-02002-w. Epub 2021 Aug 27. Int Ophthalmol. 2022. PMID: 34453229 Review.
-
Comparisons of actin filament disruptors and Rho kinase inhibitors as potential antiglaucoma medications.Expert Rev Ophthalmol. 2012 Apr;7(2):177-187. doi: 10.1586/eop.12.12. Expert Rev Ophthalmol. 2012. PMID: 22737177 Free PMC article.
-
Effects of prostaglandin analogues on aqueous humor outflow pathways.J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):102-9. doi: 10.1089/jop.2013.0179. Epub 2013 Dec 20. J Ocul Pharmacol Ther. 2014. PMID: 24359106 Free PMC article. Review.
-
Deconstructing aqueous humor outflow - The last 50 years.Exp Eye Res. 2020 Aug;197:108105. doi: 10.1016/j.exer.2020.108105. Epub 2020 Jun 23. Exp Eye Res. 2020. PMID: 32590004 Free PMC article. Review.
-
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.Ophthalmology. 2018 Nov;125(11):1741-1756. doi: 10.1016/j.ophtha.2018.04.040. Epub 2018 Jul 12. Ophthalmology. 2018. PMID: 30007591 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources